Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5002 total record number 30 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 451 out of 501
5002 citations found

Selective distribution of GABA(A) receptor subtypes in mouse spinal dorsal horn neurons and primary afferents.

Paul, J;Zeilhofer, HU;Fritschy, JM;

Product: Anti-Cholera Toxin B Subunit (Goat)

Product: Anti-Cholera Toxin B Subunit (Goat)

  • Immunohistochemistry:

    … For visualization of Fos in CTb neurons, Fos was stained as described above followed by incubating the same tissue sections in goat anti-CTb (1:20,000 List Labs) overnight, and then biotinylated donkey anti-goat secondary (1:500, Jackson), followed by ABC (1:500). Finally, sections were incubated in DAB to yield a brown reaction product in the cytoplasm.

Product: LPS from Salmonella minnesota R595 (Re)

MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury

Chassin, C;Hempel, C;Stockinger, S;Dupont, A;Kbler, JF;Wedemeyer, J;Vandewalle, A;Hornef, MW;

Product: LPS from Escherichia coli K12, D31m4 (Re)

  • Reagents:

    Escherichia coli K12 D31m4 LPS was obtained from List Biological Laboratories

    Human intestinal biopsies:

    … Biopsies were subjected to hypoxia as described. After 2h, samples were washed 3 times with prewarmed 0.9% NaCl, incubated for 2h in cell culture medium in the absence or presence of 100ng/ml LPS and analysed. Immunostaining for HIF1 and IRAK1 was performed on tissue sections from patients undergoing tissue resection following mesenteric infarction or cancer.

PATIENTS WITH RHEUMATOID ARTHRITIS

Niederer, F;

Product: LPS from Escherichia coli J5 (Rc)

  • … RASFs and primary peripheral monocytes from healthy individuals were plated in 12- and 24-well plates (5 x 104 and 3-5 x 105 cells/well) in 500 l supplemented DMEM and RPMI, respectively, and stimulated for the indicated time points with the following agents: 300 ng/ml Pam3CSK4, 10 g/ml poly(I:C) (both InvivoGen, San Diego, CA), 10 ng/ml lipopolysaccharide (LPS from Escherichia coli J5; List Biologicals, Campbell, CA), …

Product: LPS from Salmonella typhimurium

Product: Unspecified List Labs LPS

Product: Unspecified List Labs LPS

  • … Each conditioned medium was sterile ltered and 10% v/v was added to the control media for subsequent cell treatment. For positive cell activation controls, 1 mg/ml LPS (endotoxin, List Biological Laboratories Inc., Campbell, USA) was added to control media. …

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Product: Unspecified List Labs LPS

  • … Briefly, media containing 100 U/mL IFN-, (R&D Systems, Minneapolis, MN), 100 ng/mL LPS (List Biological, Campbell, CA) and 5 4g/mL antiIL-10 (R&D Systems) was added to BMMs that had adhered to glass-bottom dishes.

    Author did not specify which List Labs LPS product was utilized in their research.  List Labs provides the following LPS products:  https://listlabs.com/product-information/lipopolysaccharides/

Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men

Aikawa, N;Okubo, Y;Lynn, M;Rossignol, DP;Wong, YN;Schuck, E;Kitahara, Y;Nakano, T;Sivak, O;Wasan, KM;Nagy, C;Yen, M;

Product: LPS from Escherichia coli O111:B4

  • Pharmacodynamic assessments:

    Ex vivo activity of eritoran was assessed as previously described.11 Human studies in healthy volunteers used an ex vivo pharmacodynamic assay to assess the inhibitory activity of eritoran on endotoxin-stimulated tumor necrosis factor (TNF)-a production in whole blood collected from all men pre-dose and at 4, 8, 12, 24, 32, 48, 56, 72, 80, 120 and 168h after the start of the infusion. Briey, endotoxin from Escherichia coli 01111:B4 (List Biological Laboratories Inc. (Campbell, CA, USA), concentrations: 0, 0.05, 1 or 10ng/ml) was added to whole blood drawn from the men before and after administration of placebo or eritoran; cellular activation was assessed by measuring release of TNF-a.6,7 …